Sumitomo Pharma Co., Ltd. (DNPUF)

Sumitomo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,675	1,934	1,045	2,421	3,952	6,922
Market Cap Growth	317.46%	85.01%	-56.82%	-38.75%	-42.91%	33.63%
Enterprise Value	8,106	3,864	3,527	2,604	4,995	8,376
Last Close Price	14.36	4.76	2.40	6.38	10.22	18.75
PE Ratio	6.38	12.26	-	-	8.51	13.62
PS Ratio	2.22	0.73	0.50	0.58	0.86	1.48
PB Ratio	3.72	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	42.92	36.19	-	92.74	20.09	5.91
P/OCF Ratio	32.96	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	2.85	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	9.15	15.00	-	-	6.17	12.04
EV/EBIT Ratio	10.91	44.43	-	-	10.12	17.06
EV/FCF Ratio	52.12	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	0.99	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	1.89	8.14	-	-	2.89	3.78
Debt / FCF Ratio	11.42	39.27	-	99.82	11.91	2.24
Asset Turnover	0.56	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.81	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.83	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.36	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	81.47%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	9.25%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Capital (ROIC)	14.15%	1.52%	-33.20%	-9.23%	3.95%	3.60%
Return on Capital Employed (ROCE)	20.20%	2.60%	-90.60%	-16.50%	5.80%	5.30%
Earnings Yield	15.66%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	2.33%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.48%	2.26%	1.35%
Payout Ratio	0.00%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.48%	2.26%	1.35%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.